InterCure (INCR) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

InterCure Revenue Highlights


Latest Revenue (Y)

$355.55M

Latest Revenue (Q)

$73.47M

InterCure Revenue by Period


InterCure Revenue by Year

DateRevenueChange
2023-12-31$355.55M-8.52%
2022-12-31$388.68M76.93%
2021-12-31$219.68M237.78%
2020-12-31$65.03M628.60%
2019-12-31$8.93M100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--100.00%
2015-12-31$1.40M-75.20%
2014-12-31$5.65M-31.51%
2013-12-31$8.25M-2.59%
2012-12-31$8.47M-29.82%
2011-12-31$12.07M-8.76%
2010-12-31$13.23M-

InterCure generated $355.55M in revenue during NA 2023, up -8.52% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

InterCure Revenue by Quarter

DateRevenueChange
2023-12-31$73.47M-
2023-09-30$73.47M-28.28%
2023-06-30$102.44M-3.52%
2023-03-31$106.17M0.54%
2022-12-31$105.61M5.01%
2022-09-30$100.57M5.56%
2022-06-30$95.28M9.23%
2022-03-31$87.23M9.45%
2021-12-31$79.70M29.19%
2021-09-30$61.70M36.40%
2021-06-30$45.23M36.85%
2021-03-31$33.05M21.99%
2020-12-31$27.09M20.43%
2020-09-30$22.50M101.14%
2020-06-30$11.19M162.62%
2020-03-31$4.26M132.99%
2019-12-31$1.83M-29.64%
2019-09-30$2.60M-6.45%
2019-06-30$2.78M61.17%
2019-03-31$1.72M100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31--100.00%
2015-12-31$49.80K-85.09%
2015-09-30$333.98K-26.98%
2015-06-30$457.35K-16.24%
2015-03-31$546.04K-46.90%
2014-12-31$1.03M-2.77%
2014-09-30$1.06M-18.91%
2014-06-30$1.30M-36.54%
2014-03-31$2.06M-11.94%
2013-12-31$2.33M38.32%
2013-09-30$1.69M-9.64%
2013-06-30$1.87M-24.04%
2013-03-31$2.46M30.56%
2012-12-31$1.88M2.16%
2012-09-30$1.84M-15.73%
2012-06-30$2.19M-8.71%
2012-03-31$2.40M-20.59%
2011-12-31$3.02M-
2011-09-30$3.02M-
2011-06-30$3.02M-
2011-03-31$3.02M-8.76%
2010-12-31$3.31M-
2010-09-30$3.31M-
2010-06-30$3.31M-
2010-03-31$3.31M-

InterCure generated $73.47M in revenue during Q4 2023, up 0.00% compared to the previous quarter, and up 73.05% compared to the same period a year ago.

InterCure Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
PBHPrestige Consumer Healthcare$1.13B$267.14M
PAHCPhibro Animal Health$977.89M$263.22M
PCRXPacira BioSciences$674.98M$178.02M
COLLCollegium Pharmaceutical$566.77M$144.92M
INCRInterCure$355.55M$73.47M
EGRXEagle Pharmaceuticals$316.61M$64.65M
SSICSilver Spike Investment$11.72M$2.76B
IXHLIncannex Healthcare--
RGCRegencell Bioscience--

INCR Revenue FAQ


InterCure's yearly revenue for 2023 was $355.55M, representing a decrease of -8.52% compared to 2022. The company's yearly revenue for 2022 was $388.68M, representing an increase of 76.93% compared to 2021. INCR's yearly revenue for 2021 was $219.68M, representing an increase of 237.78% compared to 2020.

InterCure's quarterly revenue for Q4 2023 was $73.47M, a 0% increase from the previous quarter (Q3 2023), and a -30.43% decrease year-over-year (Q4 2022). The company's quarterly revenue for Q3 2023 was $73.47M, a -28.28% decrease from the previous quarter (Q2 2023), and a -26.95% decrease year-over-year (Q3 2022). INCR's quarterly revenue for Q2 2023 was $102.44M, a -3.52% decrease from the previous quarter (Q1 2023), and a 7.52% increase year-over-year (Q2 2022).

InterCure's revenue growth rate for the last 3 years (2021-2023) was 61.85%, and for the last 5 years (2019-2023) was 3883.34%.